Our data indicate that amplification of the MYC locus and loss of the RB/INTS6 locus occurs in all mouse and human tumor groups, and that AURKA amplification occurs in mouse and human BRCA2-mutated tumors. The gene discussed is INTS6; the disease is neoplasm.